首页|环状RNA在视网膜母细胞瘤的研究进展

环状RNA在视网膜母细胞瘤的研究进展

扫码查看
视网膜母细胞瘤(RB)是婴幼儿最常见的原发性眼内恶性肿瘤,严重影响患儿的视功能,当发生全身转移时可危及生命。环状RNA(circRNA)是一类最新发现的非编码RNA,主要通过竞争性结合微小核糖核酸参与调控基因的表达。circRNA可作为促癌或抑癌因子调控RB细胞的增殖、迁移、凋亡、自噬及耐药等多种生物学过程,为RB提供新的药物治疗靶点。此外,肿瘤组织或外泌体中circRNA的差异表达有望成为RB潜在的生物标志物。对于circRNA在RB中的功能和调控机制仍然需要进一步的研究和探索,以揭示其在生物体内的精确作用和潜在的临床应用。
Research progress of circRNA in retinoblastoma
Retinoblastoma(RB),the most common primary intraocular malignancy in infants and young children,poses a serious threat to visual function and the life of children when systemic metastasis occurs.Circular RNA(circRNA)is a recently discovered class of non-coding RNA that mainly functions as competitive endogenous RNA by regulating gene expression through competing with microRNA.circRNA can function as oncogenes or tumor suppressors,regulating various biological processes in RB cells,such as proliferation,migration,apoptosis,autophagy,and drug resistance,thereby providing new therapeutic targets for RB.In addition,the differential expression of circRNA in tumor tissues or exosomes is expected to be a potential biomarker for RB.Further studies and explorations are still needed for the functions and regulatory mechanisms of circRNA in RB to reveal their precise roles in organisms and potential clinical applications.

RetinoblastomacircRNACancer biomarkerMolecular targeting treatmentReview

魏朋雪、梁佳、王世静、方冬、张少冲

展开 >

暨南大学第二临床医学院,深圳 518020

暨南大学附属深圳眼科医院深圳市眼病防治研究所,深圳 518040

视网膜母细胞瘤 环状RNA 肿瘤标记物 分子靶向治疗 综述

国家自然科学基金广州省自然科学基金面上项目深圳三名工程医学项目深圳市科技计划项目

822711022021A1515011090SZSM202011015KCXFZ20211020163813019

2024

中华眼底病杂志
中华医学会

中华眼底病杂志

CSTPCD北大核心
影响因子:0.928
ISSN:1005-1015
年,卷(期):2024.40(6)